Treatment and prevention of cancer with HMGB1 antagonists

作者: Marco E. Bianchi , Haining Yang , Michele Carbone

DOI:

关键词:

摘要: Embodiments provided herein relate to methods and compositions for treating or preventing cancer. More particularly, several embodiments are drawn malignant mesothelioma with antagonists of HMGB1.

参考文章(279)
Chixu Chen, Lisa A. Ahlberg Randall, R. Bryan Miller, A. Daniel Jones, Mark J. Kurth, "Analogous" Organic Synthesis of Small-Compound Libraries: Validation of Combinatorial Chemistry in Small-Molecule Synthesis Journal of the American Chemical Society. ,vol. 116, pp. 2661- 2662 ,(1994) , 10.1021/JA00085A073
Willem P. C. Stemmer, Methods for in vitro recombination ,(1994)
Viswanathan B, X ray diffraction NCCR internal bulletin. ,(2010)
Arthur Dale Riggs, Herbert Louis Heyneker, Ronald Burnell Wetzel, William Evans Holmes, Shmuel Cabilly, Recombinant immunoglobin preparations ,(1983)
David M. Goldenberg, Sung-Ju Moon, Serengulam V. Govindan, Immunoconjugates with an intracellularly-cleavable linkage ,(2009)
Christopher A Lipinski, Franco Lombardo, Beryl W Dominy, Paul J Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Advanced Drug Delivery Reviews. ,vol. 46, pp. 3- 26 ,(1997) , 10.1016/S0169-409X(00)00129-0
Robert L. Shields, Jadine Lai, Rodney Keck, Lori Y. O'Connell, Kyu Hong, Y. Gloria Meng, Stefanie H. A. Weikert, Leonard G. Presta, Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity Journal of Biological Chemistry. ,vol. 277, pp. 26733- 26740 ,(2002) , 10.1074/JBC.M202069200